Abstract:Abstract Digital analysis of pathology whole-slide images is fast becoming a game changer in cancer diagnosis and treatment. Specifically, deep learning methods have shown great potential to support pathology analysis, with recent studies identifying molecular traits that were not previously recognized in pathology H&E whole-slide images. Simultaneous to these developments, it is becoming increasingly evident that tumor heterogeneity is an important determinant of cancer prognosis and susceptibility to treatment, and should therefore play a role in the evolving practices of matching treatment protocols to patients. State of the art diagnostic procedures, however, do not provide automated methods for characterizing and/or quantifying tumor heterogeneity, certainly not in a spatial context. Further, existing methods for analyzing pathology whole-slide images from bulk measurements require many training samples and complex pipelines. Our work addresses these two challenges. First, we train deep learning models to spatially resolve bulk mRNA and miRNA expression levels on pathology whole-slide images (WSIs). Our models reach up to 0.95 AUC on held-out test sets from two cancer cohorts using a simple training pipeline and a small number of training samples. Using the inferred gene expression levels, we further develop a method to spatially characterize tumor heterogeneity. Specifically, we produce tumor molecular cartographies and heterogeneity maps of WSIs and formulate a heterogeneity index (HTI) that quantifies the level of heterogeneity within these maps. Applying our methods to breast and lung cancer slides, we show a significant statistical link between heterogeneity and survival. Our methods potentially open a new and accessible approach to investigating tumor heterogeneity and other spatial molecular properties and their link to clinical characteristics, including treatment susceptibility and survival.

Spatial biology of cancer evolution

Spatial landscapes of cancers: insights and opportunities

Spatial omics: Navigating to the golden era of cancer research

Spatial oncology: Translating contextual biology to the clinic

Spatial genomics maps the structure, nature and evolution of cancer clones

Tumour evolution and microenvironment interactions in 2D and 3D space

Spatial structure increases the waiting time for cancer

Mapping cancer biology in space: applications and perspectives on spatial omics for oncology

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology

Insights and Opportunity Costs in Applying Spatial Biology to Study the Tumor Microenvironment

Evolution under Spatially Heterogeneous Selection in Solid Tumors

Spatial omics technologies for understanding molecular status associated with cancer progression

Applicability of Spatial Technology in Cancer Research

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Crosstalk between tumor and microenvironment: Insights from spatial transcriptomics

Spatial model predicts dispersal and cell turnover cause reduced intra-tumor heterogeneity

Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment

An Evolutionary Genetic Perspective on Cancer Biology

Advances in spatial multi-omics in tumors

High-density sampling reveals volume growth in human tumours